Affiliation:
1. Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
2. International Research Center for Medicinal Administration, Peking University, Beijing 100191, China
Abstract
Background: Antimicrobial resistance, exacerbated by antibiotic misuse, poses a global threat. Though delayed antibiotic prescribing (DAP) can mitigate antibiotic overuse, its adoption in developing nations, such as China, is limited. This study probed barriers and facilitators to DAP in Xinjiang, characterized by extensive rural landscapes and primary care institutions (PCIs). Methods: Adopting a qualitative methodology, we conducted key informant interviews with thirty participants across six county hospitals in Xinjiang using VooV Meeting. Employing a two-stage sampling method targeting economically diverse areas, our interviews spanned physicians, pharmacists, patients, and caregivers. We organized the data according to the Theoretical Domains Framework (TDF) and the Behavior Change Wheel (BCW), spotlighting behavioral and policy elements impacting DAP. Results: Our research included thirty interviewees. Twelve physicians contemplated delayed prescriptions, while five adult patients and six caregivers encountered recommendations for delayed antibiotic prescriptions. Six patients sought pharmacists’ advice on antibiotic necessity. Prominent TDF domains were memory, attention, and beliefs about consequences. Critical intervention functions included education and environmental restructuring, while vital policy categories encompassed communication/marketing and guidelines. Conclusions: Countering antibiotic misuse and resistance in China necessitates overcoming barriers through strategic resource distribution, comprehensive education, rigorous training, and consistent monitoring, thereby promoting DAP adoption. The adoption of DAP in rural healthcare settings in China has the potential to significantly reduce antibiotic misuse, thereby mitigating the global threat of antimicrobial resistance.
Funder
National Natural Science Foundation of China award
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology
Reference22 articles.
1. Antimicrobial Resistance Collaborators (2022). Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. Lancet, 399, 629–655.
2. Antimicrobial Resistance: Implications and Costs;Dadgostar;Infect. Drug Resist.,2019
3. Exposure to World Health Organization’s AWaRe Antibiotics and Isolation of Multidrug Resistant Bacteria: A Systematic Review and Meta-Analysis;Sulis;Clin. Microbiol. Infect.,2022
4. Is There a Conflict between General Practitioners Applying Guidelines for Antibiotic Prescribing and Including Their Patients’ Preferences?;Brabers;Patient Prefer. Adherence,2018
5. Interventions to Facilitate Shared Decision Making to Address Antibiotic Use for Acute Respiratory Infections in Primary Care;Coxeter;Cochrane Database Syst. Rev.,2015